| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Solvay SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €32.68 |
| 52 Week High | €113.10 |
| 52 Week Low | €17.88 |
| Beta | 0.91 |
| 11 Month Change | -4.45% |
| 3 Month Change | 31.20% |
| 1 Year Change | -68.03% |
| 33 Year Change | -69.90% |
| 5 Year Change | -63.58% |
| Change since IPO | -67.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NZR | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 2.9% | -0.4% | -1.0% |
| 1Y | -68.0% | -27.8% | 7.3% |
Return vs Industry: 0NZR underperformed the UK Chemicals industry which returned -27.8% over the past year.
Return vs Market: 0NZR underperformed the UK Market which returned 7.3% over the past year.
Price Volatility
| 0NZR volatility | |
|---|---|
| 0NZR Average Weekly Movement | 5.7% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0NZR's share price has been volatile over the past 3 months.
Volatility Over Time: 0NZR's weekly volatility has decreased from 12% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1863 | 9,000 | Philippe Kehren | www.solvay.com |
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market.
Solvay SA Fundamentals Summary
| 0NZR fundamental statistics | |
|---|---|
| Market cap | €3.45b |
| Earnings (TTM) | €127.00m |
| Revenue (TTM) | €5.57b |
27.2x
P/E Ratio0.6x
P/S RatioIs 0NZR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NZR income statement (TTM) | |
|---|---|
| Revenue | €5.57b |
| Cost of Revenue | €4.33b |
| Gross Profit | €1.24b |
| Other Expenses | €1.12b |
| Earnings | €127.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
| Earnings per share (EPS) | 1.21 |
| Gross Margin | 22.32% |
| Net Profit Margin | 2.28% |
| Debt/Equity Ratio | 155.6% |
How did 0NZR perform over the long term?
See historical performance and comparison